Top Purchase Related
Home
>
Node
>
Subnode

Peptide technology

Green, G.

Australian Journal of Biotechnology 4(3): 163-165

1990

ISSN/ISBN: 0819-3355
PMID: 1366714
Document Number: 353937

Document emailed within 1 workday
Secure & encrypted payments

Mock, K. 1993: Routine sensitive peptide mapping using LC/MS of therapeutic proteins produced by recombinant DNA technology Peptide Research 6(2): 100-104
Kraan, J.; Arroz, M.; Keeney, M.; Freire, M.; Weir, K.; Heijnen, I.; Gratama, J.W. 2003: Flow cytometric enumeration of Class i HLA-restricted, peptide-specific CD8+ T lymphocytes using tetramer technology and single-platform absolute T-cell counting Journal of Biological Regulators and Homeostatic Agents 17(3): 268-278
Jørgensen, M.S.; Jørgensen, U. 2009: Green technology foresight of high technology: a social shaping of technology approach to the analysis of hopes and hypes Technology Analysis-Strategic Management 21(3): 363-379
Honda, H. 2017: Screening and design of short length functional peptide by peptide array Seikagaku. Journal of Japanese Biochemical Society 89(1): 15-20
Krezel, A.; Mylonas, M.; Kopera, E.; Bal, W. 2006: Sequence-specific Ni(II)-dependent peptide bond hydrolysis in a peptide containing threonine and histidine residues Acta Biochimica Polonica 53(4): 721-727
Taurog, J.D.; Hammer, R.E.; Ricardson, J.A.; Satumtira, N.; Slaughter, C.A.; Butcher, G.W.; Howard, J.C.; Leong, L.Y. 1999: Rat MHC-linked peptide transporter alleles strongly influence peptide binding by HLA-B27 but not B27-associated inflammatory disease Journal of Immunology 163(10): 5741
Schafer, P.H.; Green, J.M.; Malapati, S.; Gu, L.; Pierce, S.K. 1996: HLA-DM is present in one-fifth the amount of HLA-DR in the class Ii peptide-loading compartment where it associates with leupeptin-induced peptide (LIP)-HLA-DR complexes Journal of Immunology 157(12): 5487-5495
Zong, X.; Cai, J.; Pang, L.; Liu, J.; Jiang, D.; Wang, W. 2009: Screening human keratinocyte growth factor mimic peptide with Ph.D.-7 phage display peptide library Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 23(2): 183-187
Gho, Y.S.; Lee, J.E.; Oh, K.S.; Bae, D.G.; Chae, C.B. 1997: Development of antiangiogenin peptide using a phage-displayed peptide library Cancer Research 57(17): 3733-3740
Qiu, W.-C.; Wang, Z.-G.; Wang, W.-G.; Zheng, Q. 2008: Effect and mechanism of ghrelin and its synthetic peptide growth hormone releasing peptide 6 on gastric motor in mice Zhonghua Wei Chang Wai Ke Za Zhi 11(2): 172-176
Zaks, T.Z.; Rosenberg, S.A. 1998: Immunization with a peptide epitope (p369-377) from HER-2/neu leads to peptide-specific cytotoxic T lymphocytes that fail to recognize HER-2/neu+ tumors Cancer Research 58(21): 4902-4908
Jeannin, L.; Sapi, J.; Cartier, D.; Laronze, J.Y.; Maigret, B.; Penke, B. 1997: Synthesis of peptide and pseudo-peptide analogs of cholecystokinin Annales Pharmaceutiques Francaises 55(3): 135-140
Hayes, B.K.; Esquivel, F.; Bennink, J.R.; Yewdell, J.W.; Varki, A. 1995: Structure of the N-linked oligosaccharides of MHC class I molecules from cells deficient in the antigenic peptide transporter. Implications for the site of peptide association Journal of Immunology 155(8): 3780-3787
Adams, S.; Albericio, F.; Alsina, J.; Smith, E.R.; Humphreys, R.E. 1997: Biological activity and therapeutic potential of homologs of an Ii peptide which regulates antigenic peptide binding to cell surface MHC class II molecules Arzneimittel-Forschung 47(9): 1069-1077
Boitte, P 2005: Between technology and humanity: the impact of technology on health care ethics Journal of Medical Ethics 31(1): E4-E4
Arecco, D.; Bassi, M.; Gabrielli, B.; Merlini, A. 1976: Technology of pharmaceutic powders: tablets produced using a special technology Bollettino Chimico Farmaceutico 115(10): 680-701
Wamuyu, P Kanyi 2015: The Impact of Information and Communication Technology Adoption and Diffusion on Technology Entrepreneurship in Developing Countries: The Case of Kenya Information Technology for Development 21(2): 253-280
Paukovits, J.B.; Paukovits, W.R.; Laerum, O.D. 1986: Identification of a regulatory peptide distinct from normal granulocyte-derived hemoregulatory peptide produced by human promyelocytic HL-60 leukemia cells after differentiation induction with retinoic acid Cancer Research 46(9): 4444-4448
1983: Technology. Joint model for local agreement on new technology Sygeplejersken 83(7): 20-3 28
Rothman, B.K. 1998: Ideology and technology: the social context of procreative technology Mount Sinai Journal of Medicine new York 65(3): 201-209; Discussion: 215-223